🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Autolus Therapeutics plc

AUTL Healthcare
$0.907 $-0.07 (-7.38%)
Market Cap: $241.65 M
Gurus Holding
2
Popularity Rank
#3872
% of Shares Held
0.99%
Net Activity (Q3 2026)
+$1.11 M

Guru Ownership Trend

Guru Analysis for Autolus Therapeutics plc (AUTL)

Autolus Therapeutics plc (AUTL), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.38 M.

Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.

Institutional sentiment is currently Bullish. This is evidenced by a $1.11 M net inflow during the quarter.

Recent activity highlights Steven Cohen who increased their stake by 88.7%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$1.11 M
Total Buy Value
New Buys 0
Additions 2
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
0
Net Buyers
2

FAQs for Autolus Therapeutics plc (AUTL)

Major holders include Renaissance Technologies (RenTech) ($4.84 M), Steven Cohen ($260,775). According to the latest reported data, 2 tracked investment managers collectively hold approximately 2.63 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.11 M, with 2 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in AUTL during the most recent reporting period.

Yes, 0 managers opened new positions in AUTL, and 2 increased their existing holdings. The total reported buy value was $1.11 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Add 25.6% 2,492,900 $4.84 M Q3 2026
0.00% Add 88.7% 134,420 $260,775 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form